InsidersTradesSigma
Follow the 羚锐制药 share price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 羚锐制药 has published 5 public disclosures. Market capitalisation: €13.1bn. The latest transaction was reported on 24 May 2024 (Sale). Among the most active insiders: 吴希振. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
羚锐制药 is a company operating in the health and pharmaceutical sector, listed on the XSHG market. It focuses on the research, development, and manufacturing of pharmaceutical products.